Genesis Drug Discovery & Development

Genesis Drug Discovery & Development is owned by Genesis Biotechnology Group.

Genesis Biotechnology Group has 3 subsidiaries including Genesis Drug Discovery & Development, Genesis Investment Properties and Medical Diagnostic Laboratories.

They are in:

• Biotechnology75%
• Real Estate25%

View the org chart displaying its 3 main executives

Most searched biographies at Genesis Drug Discovery & Development

• Anthony Rohr, Chief Executive Officer, PharmOptima and Chief Opera...
• Chiayu Huang, Chief Scientific Officer, Chemistry
• James Beasely, Chief Scientific Officer, Biochemistry and Bioanaly...

Create your alert
to follow the executive moves at Genesis Drug Discovery & Development.

Genesis Biotechnology Group has 2,275 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).
• Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).
• Nuvation Bio has announced the acquisition of AnHeart  (posted on April 12 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Genesis Drug Discovery & Development

• Genesis Drug Discovery & Development
• Genesis Drug Discovery & Development
• Genesis Drug Discovery & Development
• Genesis Drug Discovery & Development
• Genesis Drug Discovery & Development
• Genesis Drug Discovery & Development
• View more press releases Close

Social media about Genesis Drug Discovery & Development

• Genesis Drug Discovery & Development on Wikipedia, Google News & Yahoo Finance
• Genesis Drug Discovery & Development on LinkedIn, Twitter & YouTube

Contact by email its executives including James Beasely

Call Genesis Drug Discovery & Development at +1 844...

View the org chart

Register to receive your alert

Report an error